文献速递脊柱关节炎

68Ga-FAPI与18F-NaF PET/CT在银屑病关节炎中的比较研究

68Ga-FAPI and 18F-NaF PET/CT in psoriatic arthritis: a comparative study.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

这项前瞻性研究纳入16例银屑病关节炎患者,同期行68Ga-FAPI与18F-NaF双示踪剂PET/CT、临床评估和超声检查。68Ga-FAPI在外周关节的阳性率高于附着点和中轴关节,而18F-NaF在三处均呈高阳性率;68Ga-FAPI的PET关节计数与压痛关节数、肿胀关节数、DAS28-CRP、PASDAS及PsASon13正相关。

要点

  • 68Ga-FAPI在外周关节、附着点、中轴关节的阳性率分别为21.84%、12.15%、0%。
  • 18F-NaF在外周关节、附着点、中轴关节的阳性率分别为85.23%、78.13%、75%。
  • 68Ga-FAPI PET阳性组DAS28高于阴性组(5.25±1.84 vs 2.55±0.94,P=0.037)。

核心结论

  • 68Ga-FAPI与18F-NaF PET/CT在银屑病关节炎患者外周关节、附着点和中轴关节的阳性率不同。
  • 68Ga-FAPI PET/CT显示的关节受累范围与临床及超声变量以及疾病活动度相关。

研究设计与样本

  • 前瞻性研究,纳入16例银屑病关节炎患者(女性7/16,年龄42.31±10.66岁),行双示踪剂PET/CT、临床评估和超声检查。
  • PET/CT图像对外周关节、附着点和中轴关节的PET阳性病灶进行评分。
  • 试验注册号NCT05686876。

主要发现

  • 68Ga-FAPI在外周关节的阳性率高于附着点和中轴关节(21.84% vs 12.15% vs 0%)。
  • 18F-NaF在外周关节、附着点和中轴关节均呈高阳性率(85.23%、78.13%和75%)。
  • 68Ga-FAPI PET阳性组DAS28高于阴性组(5.25±1.84 vs 2.55±0.94,P=0.037),18F-NaF未见此差异。
  • 68Ga-FAPI PET关节计数与压痛关节数(r=0.604,P=0.017)、肿胀关节数(r=0.773,P=0.001)、DAS28-CRP(r=0.556,P=0.032)、PASDAS(r=0.540,P=0.038)及PsASon13(r=0.701,P=0.005)正相关。
  • 18F-NaF PET/CT未见上述相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: As fibroblast-like synoviocyte activation and bone formation are associated with PsA, PET using the tracers of 68Ga-fibroblast activation protein inhibitor (FAPI) and 18F-sodium fluoride (NaF) may sensitively detect the disease. In this prospective study, we aimed to evaluate the performance of 68Ga-FAPI PET/CT in PsA and to compare it with 18F-NaF PET/CT. METHODS: Sixteen participants (female 7/16, age 42.31 ± 10.66 years) with PsA were prospectively enrolled and underwent dual-tracer PET/CT, clinical assessment and ultrasonography. PET/CT images were scored for PET-positive lesions at the peripheral joints, entheses, and axial joints. RESULTS: The positivity rate of 68Ga-FAPI in peripheral joints was higher than that in entheses and axial joints (21.84% vs 12.15% vs 0%), whereas high positivity rates of 18F-NaF in peripheral joints, entheses, and axial joints were observed (85.23%, 78.13% and 75%, respectively). The DAS 28 was higher in the PET-positive than in the PET-negative group with 68Ga-FAPI (5.25 ± 1.84 vs 2.55 ± 0.94, P = 0.037), but not with 18F-NaF. In addition, the PET joint count at 68Ga-FAPI PET/CT was positively correlated with the tender joint count (r = 0.604, P = 0.017), swollen joint count (r = 0.773, P = 0.001), DAS28-CRP (r = 0.556, P = 0.032), Psoriatic Arthritis Disease Activity Score (PASDAS) (r = 0.540, P = 0.038) and PsASon13 (r = 0.701, P = 0.005), while no correlation was observed in 18F-NaF PET/CT. CONCLUSION: The positivity rates of 68Ga-FAPI- and 18F-NaF PET/CT were different in patients with PsA in peripheral joints, entheses, and axial joints. The extent of joint involvement as shown in 68Ga-FAPI PET/CT correlated with clinical and US variables as well as with disease activity. TRIAL REGISTRATION: ClinicalTrials.gov, http://clinicaltrials.gov, NCT05686876.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yang F, Lu C, Pan Q, et al. 68Ga-FAPI and 18F-NaF PET/CT in psoriatic arthritis: a comparative study. Rheumatology (Oxford). 2025. PMID: 39576694. doi:10.1093/rheumatology/keae577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。